- US-listed companies
- Organon & Co.
- Income statement
Organon & Co.【OGN】Income statement
Market cap
$2.1B
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 6,304 | 6,174 | 6,263 | 6,403 |
| Revenue growth (%) | - | |||
| Cost of revenue | 2,382 | 2,294 | 2,515 | 2,688 |
| Gross profit | - | - | - | 3,715 |
| Gross margin (%) | - | - | - | |
| Research & development | 443 | - | - | - |
| Selling, general & administrative | 1,668 | 1,704 | 1,893 | 1,760 |
| Income before tax | 1,529 | 1,122 | 673 | 807 |
| Pretax margin (%) | 24.3 | 18.2 | 10.7 | 12.6 |
| Provision for income taxes | 178 | 205 | -350 | -57 |
| Effective tax rate (%) | ||||
| Net income | 1,351 | 917 | 1,023 | 864 |
| Net income margin (%) | ||||
| Earnings per share | 5.33 | 3.61 | 4.01 | 3.36 |
| Diluted EPS | 5.31 | 3.59 | 3.99 | 3.33 |
| Dividend payout ratio (%) | ||||
| Dividend per share | 0.56 | 1.12 | 1.12 | 1.12 |